Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Isoprinosine in Patients with Severe AIDS Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on A Study of Isoprinosine in Patients with Severe AIDS conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Study of Isoprinosine in Patients with Severe AIDS Clinical research trials and A Study of Isoprinosine in Patients with Severe AIDS healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including A Study of Isoprinosine in Patients with Severe AIDS. A Study of Isoprinosine in Patients with Severe AIDS Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a A Study of Isoprinosine in Patients with Severe AIDS clinical trial. Test subjects typically receive the most effective healthcare possible for their A Study of Isoprinosine in Patients with Severe AIDS condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Study of Isoprinosine in Patients with Severe AIDS

A Study of Isoprinosine in Patients with Severe AIDS



A Study of Isoprinosine in Patients with Severe AIDS

For Condition: HIV Infections
Status: Completed
Sponsor(s): Newport Pharmaceuticals International ,
Synopsis: To evaluate the effect of Isoprinosine in patients diagnosed as having AIDS relative to: Laboratory (immunologic defects): o Comparison of total helper and suppressor T-cell numbers among the groups. o Comparison of changes in natural killer cell activity. o Comparison of other laboratory findings among the groups. Clinical changes: o Comparison of the frequency of opportunistic infections among the groups. o Comparison of the frequency of the development of AIDS-related malignancies. o Comparison of other clinical manifestations relative to severity and time of onset.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Double-Blind
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Exclusion Criteria Co-existing Condition: Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer are excluded. Concurrent Medication: Excluded: - Steroids. - Cytotoxic immunosuppressive agents. - Radiotherapy. The following are excluded: - Critically ill patients. - Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy. - Patients who have received any other immunotherapy. - Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer. Prior Medication: Excluded: - Any other immunotherapy. Patients with severe AIDS and specified laboratory immunologic defects.
Total Enrollment: 

Location and Contact Information:

Newport Pharmaceuticals International Inc
Laguna Hills,  California,  92656
United States
 


Additional Information:
Study ID Numbers:  008F;  ISO-141-USA
Study Start Date: 
Record last reviewed: June 1989
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002295

Other Hiv Infections Studies:
1. Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

2. Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

3. Safety and Effectiveness of Emtricitabine Taken Once Daily with Efavirenz and Didanosine in HIV-Infected Children Who Have Taken Few or No Anti-HIV Drugs

4. Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

5. A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination with Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment with GLQ223 or Trichosanthin

Related Studies:

Other HIV Infections Clinical Trials
Other California Clinical Trials
Other Laguna Hills Clinical Trials

A Study of Isoprinosine in Patients with Severe AIDS
Modify your Search

  Other HIV Infections Clinical Trials
  Other California Clinical Trials
  Other Laguna Hills Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103